{"id":"W2992673177","doi":"10.1182/blood-2019-128929","title":"Breakthrough Hemolysis in Adult Patients with Paroxysmal Nocturnal Hemoglobinuria Treated with Ravulizumab: Results of a 52-Week Extension from Two Phase 3 Studies","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Complement system in diseases","field":"Immunology and Microbiology","cited_by":8,"is_retracted":false,"has_abstract":true,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Paroxysmal nocturnal hemoglobinuria; Medicine; Eculizumab; Hemoglobinuria; Internal medicine; Adverse effect; Anemia; Surrogate endpoint; Gastroenterology; Surgery; Immunology; Complement system; Antibody","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008084077,0.001448495,0.002704549,0.0005985609,0.0005162877,0.001291106,0.0007840045,0.001516642,0.001700151],"category_scores_gemma":[0.002691335,0.0005511842,0.004328202,0.0005669584,0.000628191,0.001003961,0.0005335423,0.001726009,0.0004642814],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001096054,"about_ca_system_score_gemma":0.001124024,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001207359,"about_ca_topic_score_gemma":0.001912845,"domain_scores_codex":[0.9981154,0.0008825064,0.0001872003,0.0002659091,0.0002702826,0.0002787027],"domain_scores_gemma":[0.9979997,0.0004172664,0.000564814,0.000223622,0.0003275028,0.0004670863],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"observational","study_design_scores_codex":[0.6300433,0.04269151,0.03369524,0.00403337,0.01675057,0.0005016012,0.0009492822,0.002101829,0.02138126,0.0002364428,0.005270489,0.2423451],"study_design_scores_gemma":[0.4706406,0.3805132,0.1275419,0.0005131739,0.008733992,0.0008692717,0.0002258762,0.001120405,0.003177501,0.000254457,0.006278051,0.0001314045],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.96741,0.02388515,0.001066642,0.0004724211,0.0001666517,0.003971701,0.001625797,0.0001122592,0.001289347],"genre_scores_gemma":[0.9807148,0.009112855,0.001781044,0.001110807,0.0002304518,0.003244489,0.002718667,0.00002591361,0.001061006],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.008084077,"threshold_uncertainty_score":0.04275316,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01303356972150414,"score_gpt":0.257913533737659,"score_spread":0.2448799640161548,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}